-
公开(公告)号：EP2460515A1
公开(公告)日：2012-06-06
申请号：EP12155823.3
申请日：2008-08-07
申请人： Novartis AG
发明人： Arnold, Michel , Azria, Moise
IPC分类号： A61K9/20 , A61K31/198 , A61K38/23 , A61K9/16
CPC分类号： A61K38/23 , A61K9/0053 , A61K9/1635 , A61K9/1652 , A61K9/2027 , A61K9/2054 , A61K9/4866 , A61K31/198 , A61K31/59 , A61K33/06 , A61K47/16
摘要： The present invention relates to compositions for the oral delivery of pharmacologically active calcitonin, to methods of synergistically enhancing the biological effects of orally administered calcitonin with D type vitamins and calcium, and to methods of treating and/or preventing disease in mammals, particularly humans, by orally administering calcitonin compositions in accordance with the invention.
-
2.发明授权Oral calcitonin compositions and applications thereof 有权Orale Calcitonin-Zusammensetzungen und ihre Anwendungen
公开(公告)号：EP2460515B1
公开(公告)日：2017-03-08
申请号：EP12155823.3
申请日：2008-08-07
申请人： Novartis AG
发明人： Arnold, Michel , Azria, Moise
IPC分类号： A61K9/20 , A61K31/198 , A61K38/23 , A61K9/16
CPC分类号： A61K38/23 , A61K9/0053 , A61K9/1635 , A61K9/1652 , A61K9/2027 , A61K9/2054 , A61K9/4866 , A61K31/198 , A61K31/59 , A61K33/06 , A61K47/16
-
搜索结果
2 条记录 (耗时 0.01 秒)
筛选
AND
AND
过滤
NOT
NOT
扫码加群
